- 1. Polyclonal Antibody against Human PLA2R1
- (ディスカッション: 抗体Wiki)
- 一次性膜性腎症の病理診断法の一つである腎糸球体係蹄のPLA2R染色で用いるde facto standard抗体。ホルマリン固定パラフィン包埋薄切組織を用いたIFで用いることが多い。凍結IFでは明瞭な染色像が得られにくく擬陽性が得られやすい。染色プロトコルはLarsen, C. P., et al. (2013). Modern pathology :26(5): 709-715. を参照。
- 2. Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against ...
- (COVID-19)
- ... Middle East respiratory syndrome (MERS) is a threat to public health worldwide. A vaccine against ...
- 3. Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS-CoV-2 infection
- (exsome)
- ... the globally dominant D614G variant, Beta (K417N-E484K-N501Y) variant, and Delta (L452R-T478K-D614G) variant SARS-CoV-2 pseudovirus, and protect against authentic SARS-CoV-2 and Delta variant infection. ...
- 4. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia
- (COVID-19)
- Posted: 2022-01-04 20:00:00 Objective: To examine SARS-CoV-2 vaccine confidence, attitudes and intentions in ...
- 5. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
- (COVID-19)
- Posted: 2022-01-01 20:00:00 Competing interests: PMM has received consulting/speaker’s fees from Abbvie, BMS, Celgene, Eli Lilly, Galapagos, Janssen, MSD, Novartis, Orphazyme, Pfizer, Roche and UCB, ...
- 6. Immune-mediated Necrotizing Myopathy following BNT162b2 Vaccination in a Patient with Antibodies against Receptor-binding Domain of SARS-CoV-2 and Signal Recognition Particle
- (COVID-19)
- Posted: 2021-12-31 20:00:00 Muscle Nerve . 2021 Dec 30. doi: 10.1002/mus.27483. ...
- 7. Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021
- (COVID-19)
- Posted: 2021-12-30 20:00:00 Frequency: Which day? ...
- 8. Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-nine states, January-September 2021
- (COVID-19)
- Posted: 2021-12-30 20:00:00 Frequency: Which day? ...
- 9. Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature
- (COVID-19)
- Posted: 2021-12-25 20:00:00 J Neurol Sci . 2021 Dec 20;434:120102. doi: 10.1016/j.jns.2021.120102. ...
- 10. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study
- (COVID-19)
- Posted: 2021-12-24 20:00:00 Competing interests ST has received speaking fees from Roche, Astra Zeneca, Novartis and Ipsen. ST has the following patents filed: Indel mutations as a therapeutic target ...
- 11. The effects of the silence on south African children and adolescents against a global alert on the newly identified coronavirus variant: Omicron
- (COVID-19)
- Posted: 2021-12-21 20:00:00 J Pediatr Nurs . 2021 Dec 17;S0882-5963(21)00365-1. doi: 10.1016/j.pedn.2021.11.032. ...
- 12. Protective effects of exosomes derived from lyophilized porcine liver against acetaminophen damage on HepG2 cells
- (exsome)
- Posted: 2021-12-19 20:00:00 Background: Recently, extracellular vesicles have come to the fore following their ...
- 13. Protective effect of vitamin C against ivermectin induced nephrotoxicity in different age groups of male wistar rats: bio-histopathological study
- (COVID-19)
- Posted: 2021-12-10 20:00:00 Ivermectin (Ive) has exceedingly efficient against several microorganisms including viruses; therefore, it could help ...
- 14. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
- (COVID-19)
- ... of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and musculoskeletal diseases (RMDs). ...
- 15. Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice
- (exsome)
- Posted: 2021-12-05 20:00:00 Background: Several studies have shown that probiotics have beneficial effects ...
- 16. Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2
- (COVID-19)
- ... This study assessed inactivation effectiveness of twenty-four next-generation (guanidine-free) nucleic acid extraction lysis buffers and twelve rapid antigen test buffers against SARS-CoV-2, the causative ...
- 17. MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
- (COVID-19)
- Posted: 2021-12-04 20:00:00 Numerous vaccine candidates against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are under development. The majority of vaccine candidates to date ...
- 18. Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
- (COVID-19)
- ... humoral immunity after the vaccination against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Measurements of NT50 are difficult to implement in large quantities. A high-throughput laboratory ...
- 19. Effect of BCG vaccination against SARS-CoV-2 infection
- (COVID-19)
- ... 0.95, P = 0.03; I2 = 31%, and P = 0.21 for heterogeneity). Our study indicated that BCG vaccination can protect against SARS-CoV-2 infection. However, there is insufficient evidence that BCG vaccination ...
- 20. A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
- (COVID-19)
- Posted: 2021-12-01 20:00:00 Global control of COVID-19 requires broadly accessible vaccines that are effective against SARS-CoV-2 variants. In this report, we exploit the immunostimulatory ...